CAM

Cormorant Asset Management Portfolio holdings

AUM $1.34B
This Quarter Return
-8.77%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$1.1B
AUM Growth
+$1.1B
Cap. Flow
-$3.57M
Cap. Flow %
-0.32%
Top 10 Hldgs %
46.92%
Holding
73
New
12
Increased
10
Reduced
33
Closed
7
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SLDB icon
26
Solid Biosciences
SLDB
$427M
$17.5M 1.42% 652,987 -17,526 -3% -$470K
TCDA
27
DELISTED
Tricida, Inc. Common Stock
TCDA
$17.3M 1.4% 731,621 -2,967 -0.4% -$70K
TWST icon
28
Twist Bioscience
TWST
$1.63B
$16.3M 1.32% +706,064 New +$16.3M
INCY icon
29
Incyte
INCY
$16.5B
$16M 1.3% 251,335 -8,665 -3% -$551K
NBIX icon
30
Neurocrine Biosciences
NBIX
$13.8B
$15.6M 1.27% 218,222 +43,222 +25% +$3.09M
INSP icon
31
Inspire Medical Systems
INSP
$2.77B
$12.3M 1% 290,239 -9,761 -3% -$412K
ARNA
32
DELISTED
Arena Pharmaceuticals Inc
ARNA
$11.7M 0.95% 300,000 -110,000 -27% -$4.28M
SRPT icon
33
Sarepta Therapeutics
SRPT
$1.78B
$9.82M 0.8% +90,000 New +$9.82M
AMRN
34
Amarin Corp
AMRN
$311M
$9.53M 0.77% 700,000 +200,000 +40% +$2.72M
ARRY
35
DELISTED
Array Biopharma Inc
ARRY
$8.28M 0.67% 580,756 -19,244 -3% -$274K
RARX
36
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$8.03M 0.65% +441,000 New +$8.03M
ALLK
37
DELISTED
Allakos
ALLK
$7.84M 0.64% +150,000 New +$7.84M
KURA icon
38
Kura Oncology
KURA
$686M
$7.72M 0.63% +550,000 New +$7.72M
ORTX
39
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$5.9M 0.48% +375,000 New +$5.9M
RUBY
40
DELISTED
Rubius Therapeutics, Inc
RUBY
$5.8M 0.47% 360,910 -3,649 -1% -$58.7K
EIDX
41
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$5.31M 0.43% 385,846
CNST
42
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$5.1M 0.41% 1,271,687
SRRK icon
43
Scholar Rock
SRRK
$3.14B
$4.83M 0.39% 210,078
REPL icon
44
Replimune Group
REPL
$422M
$4.68M 0.38% 467,792
CTMX icon
45
CytomX Therapeutics
CTMX
$336M
$4.48M 0.36% +296,712 New +$4.48M
CFRX
46
DELISTED
ContraFect Corporation
CFRX
$4.45M 0.36% 2,905,638 -94,362 -3% -$144K
XFOR icon
47
X4 Pharmaceuticals
XFOR
$84.3M
$4.32M 0.35% +1,861,702 New +$4.32M
HRTX icon
48
Heron Therapeutics
HRTX
$207M
$4.3M 0.35% 165,682 -4,318 -3% -$112K
COLL icon
49
Collegium Pharmaceutical
COLL
$1.22B
$4.21M 0.34% 245,370 -4,630 -2% -$79.5K
NERV icon
50
Minerva Neurosciences
NERV
$16.5M
$4.1M 0.33% 607,903